AI-Powered insulin dosing shows promise for diabetes control
NCT ID NCT07291804
First seen Jan 11, 2026 · Last updated May 25, 2026 · Updated 19 times
Summary
This study tested a smart system that helps people with type 2 diabetes decide how much insulin to take. 140 adults starting insulin therapy used the system or received standard care. The goal was to see if the system improved blood sugar levels safely without increasing dangerous low blood sugar events.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510630, China
Conditions
Explore the condition pages connected to this study.